Table 2.
Concentration of EAE (µg/mL) | Cell viability ± SD (%) |
Inhibition± SD (%) |
IC50± SD value of EAE |
||||||
---|---|---|---|---|---|---|---|---|---|
HeLa | SiHa | CaSki | HeLa | SiHa | CaSki | HeLa | SiHa | CaSki | |
50 | 84.33±7.67b | 89.85±8.08b | 90.88±9.56b | 15.67±2.11f | 10.15±1.86e | 9.12±1.06f | 204.14±17.45 | 254.56±20.11 | 262.01±22.78 |
100 | 76.77±6,99c | 81.33±7.78c | 84.88±7.90bc | 23.23±2.98e | 18.67±1.90d | 15.12±2.52e | |||
150 | 58.44±5.45d | 65.84±5.23d | 72.22±6.98c | 41.56±3.79d | 34.16±3.12c | 27.78±2.67d | |||
200 | 50.45±5.21d | 55.12±4.10e | 65.55± 6.55d | 49.54±4.11c | 44.78±4.16b | 34.45±3.56c | |||
250 | 43.99±3.12e | 50.44±4.34e | 54.89±5.63e | 56.01±4.92b | 49.56±5.23b | 45.11±4.21b | |||
Control (negative) | 100a | 100a | 100a | 0 | 0 | 0 | |||
Positive control (Adriamycin 5 µg/mL) | 1.91±0.41f | 2.44±0.52f | 2.92±0.71f | 98.19±11.45a | 97.56±10.12a | 97.08±11.79a |
Note: Each data is Mean± SD (p<0.05) of three independent experiments. Same letter in the same row indicates statistically no different but different letter indicates they are statistically different as per Duncan analysis (p=0.05 level)